2,4-Hexadienoic acid, 3-(trimethoxysilyl)propyl ester, (2E,4E)-

Acute Toxicity: oral

Administrative data

Endpoint:

acute toxicity: oral

Type of information:

experimental study

Adequacy of study:

key study

Study period:

19 April - 6 June 2012

Reliability:

1 (reliable without restriction)

Rationale for reliability incl. deficiencies:

guideline study

Data source

Reference

Reference Type:

study report

Title:

Unnamed

Year:

2012

Report date:

2012

Materials and methods

Test guideline

Test guideline 1

Qualifier:

according to guideline

Guideline:

OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)

Deviations:

no

Test guideline 2

Qualifier:

according to guideline

Guideline:

EPA OPPTS 870.1100 (Acute Oral Toxicity)

Deviations:

no

GLP compliance:

yes (incl. QA statement)

Test type:

acute toxic class method

Limit test:

yes

Test material

Test material information

Constituent 1

Reference substance name:

3-(trimethoxysilyl)propyl (2E,4E)-hexa-2,4-dienoate

EC Number:

642-902-2

Cas Number:

163802-53-7

Molecular formula:

C12H22O5Si

IUPAC Name:

3-(trimethoxysilyl)propyl (2E,4E)-hexa-2,4-dienoate

Constituent 2

Reference substance name:

3-(trimethoxysilyl)propyl-(2E,4E)-hexa-2,4-dienoate

IUPAC Name:

3-(trimethoxysilyl)propyl-(2E,4E)-hexa-2,4-dienoate

Constituent 3

Reference substance name:

2,4-Hexadienoic acid, 3-(trimethoxysilyl)propyl ester, (2E,4E)-

IUPAC Name:

2,4-Hexadienoic acid, 3-(trimethoxysilyl)propyl ester, (2E,4E)-

Test material form:

liquid

Test animals

Species:

rat

Strain:

other: Wistar rats Crl: WI (Han)

Sex:

female

Details on test animals or test system and environmental conditions:

TEST ANIMALS
- Source: Charles River, Germany
- Age at study initiation: 9-10 weeks
- Weight at study initiation: 160-181 g
- Fasting period before study: 16-19 hours
- Housing: in groups in IVC cages, type III H, polysulphone cages
- Diet: Altronim 1324 maintenance diet for rats and mice, ad libitum
- Water: tap water, sulphur acidified to a pH value of 2.8, ad libitum
- Acclimation period: at least 5 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22+/- 3
- Humidity (%): 55 +/- 10
- Air changes (per hr): 10
- Photoperiod (hrs dark / hrs light): 12/12

Administration / exposure

Route of administration:

oral: gavage

Vehicle:

unchanged (no vehicle)

Remarks:

The liquid test item was tested undiluted.

Details on oral exposure:

MAXIMUM DOSE VOLUME APPLIED: 2000 mg/kg bw

Doses:

The starting dose was selected to be 2000 mg/kg body weight. No compound-related mortality was recorded for any animal of step 1 or 2 of the test guideline. Based on these results and according to the acute toxic class method regime no further testing was required.

No. of animals per sex per dose:

6 (female)

Control animals:

no

Details on study design:

- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: on day 1 (prior to administration), day 8 and 15
- Necropsy of survivors performed: yes
- Other examinations performed: observation at 30 minutes, 4 hours, then every day post-administration. Attention was paid to changes in skin and fur, eyes and mucous membranes, respiratory, circulatory, autonomic and central nervous system, somatomotor activity and behaviour pattern.

Results and discussion

Effect levels

Key result

Sex:

female

Dose descriptor:

LD50

Effect level:

> 2 000 mg/kg bw

Based on:

test mat.

Mortality:

No mortality was observed during the 14-day period of study.

Clinical signs:

other: No clinical changes were observed during the 14-day study period.

Gross pathology:

No pathological changes were observed in any of the animals.

Applicant's summary and conclusion

Interpretation of results:

GHS criteria not met

Conclusions:

In an acute oral toxicity study conducted to the OECD 402 and to GLP, the LD50 for 2,4-hexadienoic acid, 3-(trimethoxysilyl)propyl ester was > 2000 mg/kg bw in rats.

Executive summary:

Two groups, each of three female WISTAR Crl: WI(Han) rats, were treated with the test item by oral gavage administration at a dosage of 2000 mg/kg body weight. The test item was tested undiluted and administered at a dose volume of 2 mL/kg. All animals used in the study after their entrance at BSL were allowed to acclimatise to the laboratory conditions for at least 5 days. The animals were observed on delivery, on inclusion in the study and before administration for mortality/morbidity and other clinical signs. All animals were examined for clinical signs several times on the day of dosing and once daily until the end of the observation period. Their body weights were recorded on day 1 (prior to the administration) and on days 8 and 15. All animals were necropsied and examined macroscopically. All animals survived until the end of the study without showing any test-item related signs of toxicity. Throughout the 14-day observation period, the body weight gain of the test animals was within the normal range of variation for this strain. At necropsy, no macroscopic findings were observed in any animal of any step. Under the conditions of the present study, a single oral application of the test item to rats at a dose of 2000 mg/kg body weight was associated with no signs of toxicity or mortality. Therefore, the LD₅₀ for this test item is expected to be greater than 2000 mg/kg.